Key Drivers
- Strong liquidity
- High operating losses
- Premium valuation
AIAI Summary
Butterfly's strategic pivot from device sales to embedded Ultrasound‑on‑Chip licensing and AI/platform revenue meaningfully raises the upside for higher-margin, recurring revenue but only if management can deliver next‑gen chips, convert enterprise pilots into repeatable contracts, and avoid further inventory write‑downs. Monitor semiconductor yield/timing, quarterly large‑deal closures (which drive cash flow), and margin expansion as the three actionable signals that will validate or bust this thesis.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong liquidity
- •High operating losses
- •Premium valuation
BFLY has strong liquidity and gross margins but is consuming cash with very large operating losses and appears richly valued despite weak profitability.
Price Behavior
Key Price Behavior Insights:
- •Above last month SMA
- •Higher lows formed
- •Event-driven spike
BFLY sits above its last month SMA (~$3.73) with higher lows from the late‑Feb trough and neutral RSI (~53), suggesting a modest short‑term uptrend but event‑driven volatility (spike to $4.67) and choppy action argue for tight risk controls.
Sharp isolated spike to $4.67 on 2026-02-26, then reversion indicating headline/liquidity-driven volatility
Sentiment & News
Key News Insights:
- •Revenue beat
- •Loss narrowed
- •AI chip push
Butterfly Network beat Q4 and FY revenue estimates and narrowed losses while accelerating its AI/software-on-chip strategy with a new SVP for innovation amid mixed analyst sentiment.
If Butterfly executes on its embedded ultrasound-on-chip and AI licensing strategy, the company could see a gradual valuation recovery, though mixed analyst ratings and execution risk constrain near-term upside
Similar Companies in Healthcare
Other companies in the same sector with AI ratings